Represented a leading health care company in its acquisition of a publicly traded medical device company.

Represented various companies in the health care industry in strategic investments, reorganizations, affiliations, joint ventures and other transactions.

Represented special committee of privately held manufacturer in evaluating a shareholder distribution transaction.

Represented a late-stage, privately held technology company in obtaining financing for, disclosing and executing a tender offer to existing equity holders.

Represented an equity sponsor and selling stockholder in a technology company's initial public offering and secondary offerings.

Represented a NYSE-listed issuer in disclosing and obtaining supermajority shareholder approval of curative changes to legacy charter documents and obtaining remedial approvals under state ratification statute.

Represented the special board committee of a publicly traded service company in negotiating and completing a going private transaction.

Represented the audit committee of a publicly traded financial services company in conducting an internal investigation of financial and accounting matters.

Represented issuers in various industries and selling shareholders in IPO and secondary offering registrations.

Represented a public software company in its acquisition by an international information solutions provider.

Represented a manufacturer in its issuance of high-yield notes in a Rule 144A placement and subsequent registered exchange offer.

Represented private equity firms and strategic buyers in investments in publicly traded companies.

Represented publicly traded companies, their boards of directors and committees in compliance and disclosure matters under SEC regulations, exchange rules and related requirements.

Represented issuers of securities in private placements in transaction structuring, exemption compliance and related matters.